10-K: Chicago Atlantic BDC Reports Year-End Results, Navigates Complex Lending Landscape

Chicago Atlantic BDC details its investment strategy, portfolio composition, and financial performance for the year ended December 31, 2024, amid evolving market conditions.

Summary

• Chicago Atlantic BDC, Inc., a specialty finance company, released its 10-K filing detailing its financial condition and results of operations for the year ended December 31, 2024.
• The company focuses on investing in complex and regulated industries, including the cannabis ecosystem, with an investment objective to maximize risk-adjusted returns.
• The investment strategy expanded in April 2024 to include companies outside the cannabis and health and wellness sectors.
• On October 1, 2024, the company completed the acquisition of a loan portfolio from Chicago Atlantic Loan Portfolio, LLC, issuing 16,605,372 shares of its common stock in exchange.
• A joint venture was formed on October 1, 2024, to combine investment management businesses, leading to a new investment advisory agreement and a license agreement for the Chicago Atlantic name.
• The Adviser agreed to cap the company's operating expenses at an annualized rate of 2.15% of net assets through September 30, 2025.
• The company's investment portfolio had a fair value of $275.2 million as of December 31, 2024, spread across 28 portfolio companies.
• The company's investment income totaled $21.7 million for the year ended December 31, 2024.
• Net investment income was $9.5 million for the year ended December 31, 2024.
• The company had cash resources of $23.9 million and no indebtedness as of December 31, 2024.
• On February 11, 2025, the Company entered into a senior secured revolving credit agreement for up to $100 million.
• The company intends to distribute at least 90% of its taxable income each taxable year to maintain its status as a RIC.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While there's growth in investment income and portfolio size, there are also risks associated with the cannabis industry, regulatory changes, and potential economic downturns. The expansion of the investment strategy and the new credit agreement are positive developments, but the dependence on a single industry and the potential for increased competition create uncertainty.

Positives

• The company's investment strategy has been expanded to include companies outside the cannabis and health and wellness sectors.
• The company completed the acquisition of a loan portfolio, increasing its assets.
• The Adviser has agreed to cap operating expenses, which could improve profitability.
• The company's investment income increased significantly compared to the previous year.
• The company entered into a senior secured revolving credit agreement, providing additional financial flexibility.

Negatives

• The company's investments may be risky, and it could lose all or part of its investments.
• The company is subject to financial market risks, including valuation risk, interest rate risk and credit risk.
• The company is dependent on information systems and systems failures could significantly disrupt its business.
• The company may be unable to realize the benefits anticipated by the Loan Portfolio Acquisition, including estimated cost savings, or it may take longer than anticipated to achieve such benefits.

Risks

• Economic recessions or downturns may have a material adverse effect on the company's business, financial condition and results of operations.
• The company has limited operating history and its Adviser is a recently registered investment adviser.
• The company's investment portfolio will be recorded at fair value, and there will be uncertainty as to the value of its portfolio investments.
• The company may face increasing competition for investment opportunities.
• Regulations governing the company's operation as a BDC and RIC may affect its ability to raise additional capital.
• Changes in laws or regulations governing the company's operations, including laws and regulations governing cannabis, may adversely affect its business.
• The company may be unable to invest a significant portion of the net proceeds from its initial public offering, or any follow-on offering of shares of its common stock, on acceptable terms within an attractive time frame.
• The company may not be able to pay distributions, and if it is able to pay distributions, its distributions may not grow over time and/or a portion of its distributions may be a return of capital.
• The company will be subject to corporate-level U.S. federal income tax if it is unable to obtain and maintain qualification as a RIC.
• The company's investments in portfolio companies may be risky, and it could lose all or part of its investments.
• The company intends to invest primarily in securities that are rated below investment grade.
• The lack of liquidity in the company's investments may adversely affect its business.
• The market price of the company's common stock may fluctuate significantly.
• Cannabis, except for hemp, is currently illegal under U.S. federal law and in other jurisdictions, and strict enforcement of federal laws would likely result in the company's inability to execute its business plan.
• Loans to relatively new and/or small companies and companies operating in the cannabis industry generally involve significant risks.
• The company's investment opportunities are limited by the current illegality of cannabis under U.S. federal law.
• Cybersecurity risks and cyber incidents may adversely affect the company's business or the business of its portfolio companies.
• Sales of shares of the company's common stock after the completion of the Loan Portfolio Acquisition may cause the market price of its common stock to decline.
• The company may be unable to realize the benefits anticipated by the Loan Portfolio Acquisition.

Future Outlook

The company expects overall capital markets activity to remain muted until the Drug Enforcement Agency and Health and Human Services restart the public hearing process required to potentially reschedule cannabis.

Management Comments

• We expect overall capital markets activity to remain muted until the Drug Enforcement Agency and Health and Human Services restart the public hearing process required to potentially reschedule cannabis.
• Regardless of the outcome or ultimate stance the new administration takes, we continue to expect demand for credit-based solutions to increase, as companies continue to prefer less dilutive forms of growth capital and equity capital remains scarce.
• The lack of competition and financing options for cannabis businesses is as stark as we have seen in recent years and has created an opportune environment for us to make attractive growth capital investments from an advantageous position the ability to drive terms and enhance structural protections while capturing above average risk-adjusted returns.

Industry Context

The cannabis industry is experiencing growth with increasing legalization and normalization, creating investment opportunities, but it remains fragmented and subject to complex regulations.

Comparison to Industry Standards

• The capital raising environment for private credit broadly continued its strong momentum in 2024, finishing the year with $209 billion in final closingsa 5% increase over 2023, making it another blockbuster fundraising year for the asset class.
• In 2024, five private credit funds each raised $10 billion or more, accounting for $89 billion combinedwhich represented two-thirds of all direct lending fundraising and over 40% of total private credit fundraising.

Management Changes

Related Party Transactions

• The company has entered into an Investment Advisory Agreement with the Adviser, under which it pays a base management fee and an incentive fee.
• The company has entered into an Administration Agreement with the Adviser, under which it reimburses the Adviser for certain costs and expenses.
• The company has entered into a license agreement with the Adviser, granting it a nonexclusive, royalty-free license to use the name Chicago Atlantic.
• The company may co-invest with other investment vehicles managed by its affiliates.
• The Adviser and CALP have significant influence over the company, including having an approximately 80% vote for matters that require the approval of stockholders.

Stakeholder Impact

• The company's performance and investment decisions directly impact its shareholders, who are subject to the risks and rewards of the company's investments.
• The company's portfolio companies are impacted by its investment decisions and its provision of managerial assistance.
• The company's employees and service providers are subject to its code of ethics and compliance policies.
• The company's activities may impact the broader cannabis industry and the communities in which its portfolio companies operate.

Next Steps

• The company will continue to manage its investment portfolio and seek new investment opportunities.
• The company will monitor the regulatory landscape and adapt its investment strategy as needed.
• The company will distribute dividends to its stockholders.

Key Dates

Keywords

BDC, cannabis, investments, portfolio, loans, debt, capital, Adviser, RIC, secured